AN
CelLBxHealth plc
ANPCY · OTC
$0.07 +0.00% (+$0.00)
Market Cap £1.63M
P/E Ratio -
Div. Yield -
ROE 104.73%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.14x
P/S 0.62x
PEG N/A
Growth
61 /100
Stable Book val. growth 14.63%
Rev. growth 6.10%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 442.84%
Op. margin 627.67%
Gross margin 62.27%
Quality
2 /100
Poor Asset turnover 0.15x
ROA 87.26%
ROIC 105.60%
Debt
80 /100
Low Net debt/EBITDA 0.10x
Int. coverage -38.21x
Debt/Equity 0.31x
Stability
42 /100
Moderate Profitable years 0
EPS volatility 19.40%
Beta 0.14x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ANPCY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Collins
Employees
119
Headquarters
Guildford